Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Greicius

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
A 3'UTR Insertion Is a Candidate Causal Variant at the <i>TMEM106B</i> Locus Associated with Increased Risk for FTLD-TDPAugustine Chemparathy, Yann Le Guen, Yi Zeng, et al.
Annals of Neurology|January 5, 2024
Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's DiseaseJeffery M Vance, Lindsay A Farrer, Yadong Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Integration of transcriptomics and long-read genomics prioritizes structural variants in rare diseaseTanner D Jensen, Bohan Ni, Chloe M Reuter, et al.
Genome Research|March 20, 2025
Integration of transcriptomics and long-read genomics prioritizes structural variants in rare diseaseTanner D Jensen, Bohan Ni, Chloe M Reuter, et al.
American Journal of Human Genetics|November 12, 2021
Genome-wide analysis of common and rare variants via multiple knockoffs at biobank scale, with an application to Alzheimer disease geneticsZihuai He, Yann Le Guen, Linxi Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2025
<i>APOE</i> *4 Risk-Modifying Genes and Drug Targets in Alzheimer's Disease through Cell-Type Specific Genomic AnalysesYoujie Zeng, Noah Cook, Chenyu Yang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisDanielle M Reid, Noah Cook, Chenyu Yang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2026
APOE*4 risk-modifying genes and drug targets in Alzheimer's disease through cell-type-specific genomic analysesYoujie Zeng, Noah Cook, Chenyu Yang, et al.
Neurobiology of Aging|February 21, 2021
KL∗VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗4 carriersMichael E Belloy, Sarah J Eger, Yann Le Guen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Integrative Genetic, Proteogenomic, and Multi-omics Analyses Reveal Sex-Biased Causal Genes and Drug Targets in Alzheimer's DiseaseNoah Cook, Chenyu Yang, Youjie Zeng, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
A 3'UTR Insertion Is a Candidate Causal Variant at the <i>TMEM106B</i> Locus Associated with Increased Risk for FTLD-TDPAugustine Chemparathy, Yann Le Guen, Yi Zeng, et al.
Annals of Neurology|January 5, 2024
Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's DiseaseJeffery M Vance, Lindsay A Farrer, Yadong Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Integration of transcriptomics and long-read genomics prioritizes structural variants in rare diseaseTanner D Jensen, Bohan Ni, Chloe M Reuter, et al.
Genome Research|March 20, 2025
Integration of transcriptomics and long-read genomics prioritizes structural variants in rare diseaseTanner D Jensen, Bohan Ni, Chloe M Reuter, et al.
American Journal of Human Genetics|November 12, 2021
Genome-wide analysis of common and rare variants via multiple knockoffs at biobank scale, with an application to Alzheimer disease geneticsZihuai He, Yann Le Guen, Linxi Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2025
<i>APOE</i> *4 Risk-Modifying Genes and Drug Targets in Alzheimer's Disease through Cell-Type Specific Genomic AnalysesYoujie Zeng, Noah Cook, Chenyu Yang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisDanielle M Reid, Noah Cook, Chenyu Yang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2026
APOE*4 risk-modifying genes and drug targets in Alzheimer's disease through cell-type-specific genomic analysesYoujie Zeng, Noah Cook, Chenyu Yang, et al.
Neurobiology of Aging|February 21, 2021
KL∗VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗4 carriersMichael E Belloy, Sarah J Eger, Yann Le Guen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Integrative Genetic, Proteogenomic, and Multi-omics Analyses Reveal Sex-Biased Causal Genes and Drug Targets in Alzheimer's DiseaseNoah Cook, Chenyu Yang, Youjie Zeng, et al.
Pageof 15